2-5A[ppp(A2'p),A] and related materials accumulate to greater than micromolar concentrations in vaccinia virus-infected HeLa cells and in interferon-treated, vaccinia-infected HeLa, CVI, and L929 cells even when virus replication is not inhibited. A variably complex mixture of authentic 2-5A (n = 2 to 4), nonphosphorylated cores [(A2'p)nA; n = 2 to 5], and additional compounds of unknown structure was observed.
Modulation of the 2-5A system is one of the many effects of interferon (IFN) treatment of animal cells (reviewed in reference 13). The 2-SA synthetase, when activated by double-stranded RNA, polymerizes ATP into a series of 2',5'-linked oligomers [ppp(A2'p),A, n 2 2]. These oligomers, collectively called 2-5A, bind and activate a latent cellular endoribonuclease (the 2-5A-dependent RNase, RNase L or F) capable of cleaving mRNA and rRNA. As well as synthesizing 2-SA, the synthetase can add AMP in 2'-5' linkage to such metabolites as NAD+, ADP-ribose, and A5'p45'A (1, 5, 7, 14) . Although these products have not been found in intact cells (5), other unusual 2',5' oligoadenylates have been detected, the structure and function of which have not yet been determined (4, 10) .
Vaccinia virus replication is extremely sensitive to IFN in some strains of L cells grown in suspension in which protein synthesis, both cellular and viral, is rapidly inhibited. Activation of the 2-5A-dependent RNase with cleavage of rRNA and viral RNA has been reported to correlate with this general inhibition of protein synthesis (2, 6, 8) . In contrast, in other cell lines, vaccinia replication is relatively resistant to IFN and there is no correlation between 2-5A levels and inhibition of virus growth (15, 17) . In L929, HeLa, and CV1 cells we observed extraordinarily high (greater than micromolar) levels of 2-5A after vaccinia infection even when the cells were treated with too little IFN to inhibit virus growth. Similar high levels of 2-5A accumulated in untreated HeLa cells (which have high constitutive levels of 2-5A synthetase) in which vaccinia replicates well (17). A partial explanation for this apparent anomaly was provided by the observation that in this system activation of the 2-SA-dependent RNase in the intact cell lags considerably behind the accumulation of 2-5A. The enzyme itself, however, remained active in cell extracts prepared throughout infection, suggesting the presence of an inhibitor(s) in the intact cell (17). Initial results in our laboratory indicated that, in addition to authentic 2-5A, a variety of related compounds were present in substantial amounts. It seemed possible that a further analysis of this 2-5A-related material might reveal the presence of compounds capable Fig. 3A , peak J). For optimum resolution of cores a potassium phosphate-methanol gradient was used (3). The radiobinding (RB), radioimmune (RI), and rRNA cleavage assays were as described previously (11, 12, 17) . Of the assays used the rRNA cleavage and RB assays are the more specific for authentic 2-SA. Each requires the minimum structure pp(A2'p)2A for optimum sensitivity (<1 nM). For the RI assay, which uses a polyclonal antiserum, the corresponding minimum structure is p(A2'p)2A (11). All of the assays, however, detect additional 2',5' oligoadenylates with reduced sensitivity, e.g., the RI assay detects structures containing pA2'pA at 20 to 60 nM (11), and the rRNA cleavage assay detects the tetramer 5'-monophosphate p(A2'p)3A at 100 nM (9 Complex patterns of 2',5' oligoadenylates were also obtained from IFN-treated, vaccinia virus-infected CV1 cells. A particularly complex example is shown in Fig. 3 without or with prior BAP digestion ( Fig. 3A and B, respectively) . In addition to peaks of material positive in RB and rRNA cleavage assays which eluted at positions corresponding to trimer, tetramer, and pentamer 2-SA (Fig. 3A, peaks A, B, (A2'p)nA and C), a variety of additional peaks was detected. These (core) appeared to differ substantially from those present in the corresponding HeLa extract (Fig. 1B) . The major differences are that with the CV1 material (peaks D to I) the values measured in the RI assay were high compared to the values measured in the RB assay, and these peaks were active in the rRNA cleavage assays at levels consistent with their RB values (contrast peaks P to T in Fig. 1B ). In addition, the B0 CV1 material yielded many RB-positive peaks after BAP digestion (Fig. 3B ) and contained a major peak J without BAP digestion (Fig. 3A) Fig. 1A were incubated with an IFN-treated L-cell cytoplasmic extract (S-10). RNA isolated from such incubations was electrophoresed in a 1.6% neutral agarose gel (17); a photograph of the ethidium bromide-stained gel is shown. Specific 2-5A-dependent RNase This analysis has shown that 2',5' oligoadenylates in vaccinia-infected cells can consist of a variably complex mixture of authentic 2-5A, nonphosphorylated core 2-5A, and numerous additional compounds of unknown structure. These findings contrast with those in other IFN-virus systems. In IFN-treated, encephalomyocarditis virus-infected L cells, only authentic 2-5A (trimer and tetramer) and cores were detected (12) . Little authentic 2-5A was detected in CV1 cells infected with simian virus 40 and then treated with IFN, but core 2-5A and several oligoadenylates of unknown structure were found (10). In IFN-treated, herpes simplex virus type 1-infected Chang cells, authentic 2-5A (trimer and tetramer) was detected as well as two related compounds which were capable of acting as inhibitors of the 2-5A-dependent RNase in cell extracts (4). These related compounds were present in concentrations too low to permit further characterization (4). It is not clear whether any of the unknowns in the systems described above correspond to any of those detected in the present study.
The reason(s) for the lag in vaccinia-infected cells between accumulation of high levels of 2-5A and activation of the RNase (17) remains unclear. In our study, assay of selected peak fractions (not themselves capable of activating the RNase) failed to detect significant analog inhibitory activity analogous to that found in IFN-treated, herpesvirus-infected cells (4). It remains possible that such inhibitors are produced at an early or crucial time during infection or are localized at high concentrations near the RNase. Alternatively, another type of inhibitor of the RNase that is not related to 2-5A could be present which is lost during the preparation of cell extracts.
Clearly, much of the variability in the amount and nature of the 2',5' oligoadenylates in vaccinia-infected cells reflects differences between cell lines. Even within a given cell line, however, the results were so variable as to suggest extreme sensitivity to time and multiplicity of infection, 
